US Stock MarketDetailed Quotes

VIR Vir Biotechnology

Watchlist
  • 7.120
  • +0.170+2.45%
Close Nov 22 16:00 ET
980.57MMarket Cap-1811P/E (TTM)

Vir Biotechnology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Vir Biotechnology Q3 2024 Earnings Date

Currency：USDOct 31, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
5.51M
2.38M
-3.13M
Miss Est.
+108.80%
-9.81%
-56.81%
EPS
-0.96
-1.56
-0.60
Miss Est.
+21.48%
-27.87%
-62.86%
Analyst Rating
Buy

Nov 24, 2024

Vir Biotechnology Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 18.214M--
--2024/Q4-- / 9.368M--
Oct 31, 20242024/Q32.380M / 5.510M--
Aug 1, 20242024/Q23.075M / 7.497M--
May 2, 20242024/Q156.376M / 11.712M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 18.214M--
--2024/Q4-- / 9.368M--
Oct 31, 20242024/Q32.380M / 5.510M--
Aug 1, 20242024/Q23.075M / 7.497M--
May 2, 20242024/Q156.376M / 11.712M--

Unlock Free Earnings Estimates

Vir Biotechnology Earnings Reports

  • Vir Biotechnology | 10-Q: Q3 2024 Earnings Report

    Nov 5 05:16

  • Vir Biotechnology | 8-K: Vir Biotechnology Reports Third Quarter 2024 Financial Results and Provides Corporate Update

    Nov 1 04:26

  • Vir Biotechnology | 10-Q: Q2 2024 Earnings Report

    Aug 2 04:48

  • Vir Biotechnology | 8-K: Vir Biotechnology Reports Second Quarter 2024 Financial Results and Announces Strategic Restructuring to Prioritize Clinical-Stage Pipeline Opportunities

    Aug 2 04:12

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 24, 2024

    Buy

    • Buy

      57.14%

    • Hold

      42.86%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data